+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative in vitro and in vivo evaluation of himachalol in murine invasive aspergillosis

Comparative in vitro and in vivo evaluation of himachalol in murine invasive aspergillosis

Indian Journal of Experimental Biology 35(7): 727-734

Aspergilli are increasingly important infections in immunocompromised patients (ICP). The available antifungals often cause discrepancies in laboratory determination of MICs and a correlation in therapy. An effort was made to compare in vitro techniques for testing of antifungals, viz. polyenes, imidazoles, 5-fluorocytosine, amorolfine; and screened a phytoproduct- himachalol (a sesquiterpene alcohol) from Cedrus deodara (Roxb.) Loud against A. fumigatus clinical isolates (24) by macrobroth two-fold seal dilution (TFSD), microbroth microtitre (MT) and disc diffusion (DD) techniques using various broth/agar media at varying periods of incubation. The best activity in terms of geometric mean (GM) (GM.MIC < 0.39 microgrmas ml-1) was obtained with SCZ in the broth by both MT or TFSD technique followed by ECZ (GM.MIC 0.39 micrograms ml-1) and ITZ (GM.MIC 0.39-0.8 micrograms ml-1) in RPMI-1640. Overall RPMI-1640 was found to be the most suitable growth medium for testing of azoles or amorolfine, and YNB for polyene and 5-FC. MT technique was the most sensitive quantitative, reproducible, rapid and economical compared to other techniques. The treatment of Swiss mice with himachalol (200 mg kg-1, po) once a day, for 7 days, provided 60% protection concomitantly with increased MST (15 days) against invasive aspergillosis. A combination of himachalol (200 mgkg-1) plus SCZ (5 mgkg-1) showed better regimen in the therapy evidenced by enhanced survival (80%) of mice significantly (p < 0.001) with prolonged MST (> 15 days) compared to control. The treatments also reduced cfu (mean log10) burden of A. fumigatus from kidney.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 003072769

Download citation: RISBibTeXText

PMID: 9418375

Related references

Evaluation of himachalol in murine invasive aspergillosis. Mycoses 39(11-12): 449-452, 1996

A murine model of invasive aspergillosis: variable benefit of interferon-gamma administration under in vitro and in vivo conditions. Surgical Infections 6(4): 397-407, 2005

Evaluation of himachalol in murine systemic candidosis. Journal de Mycologie Medicale 9(4): 217-220, 1999

In vivo pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 445, 2003

Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis. Antimicrobial Agents and ChemoTherapy 58(11): 6767-6772, 2014

Evaluation of a PCR and culture assays to detect Aspergillus DNA in a murine model of invasive aspergillosis. Blood 98(11 Part 1): 388a-389a, 2001

Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation. Journal of Infectious Diseases 194(7): 1008-1018, 2006

RT-qPCR detection of Aspergillus fumigatus RNA in vitro and in a murine model of invasive aspergillosis utilizing the PAXgene® and Tempus™ RNA stabilization systems. Medical Mycology 50(6): 661-666, 2012

Isavuconazole (BAL4815) pharmacodynamic target determination in an in vivo murine model of invasive pulmonary aspergillosis against wild-type and cyp51 mutant isolates of Aspergillus fumigatus. Antimicrobial Agents and ChemoTherapy 57(12): 6284-6289, 2013

Development of a novel inhalational model of invasive pulmonary aspergillosis in rats and comparative evaluation of three biomarkers for its diagnosis. Plos one 9(6): E100524, 2014

Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis. Antimicrobial Agents and ChemoTherapy 51(4): 1253-1258, 2007

Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001. Clinical Infectious Diseases 37(Suppl. 3): S188-S224, 2003

Comparative evaluation of marginal integrity of glass ionomer and resin based fissure sealants using invasive and non-invasive techniques: an in vitro study. Indian Journal of Dental Research 23(3): 320-325, 2013

A Comparative Evaluation of the Effect of Bonding Agent on the Tensile Bond Strength of Two Pit and Fissure Sealants Using Invasive and Non-invasive Techniques: An in-vitro Study. Journal of Clinical and Diagnostic Research 7(10): 2343-2347, 2013

Murine model of invasive aspergillosis. Methods in Molecular Medicine 118: 129-142, 2005